Sangamo Therapeutics
(SGMO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,818 | -10,433 | -29,764 | -25,249 | -9,066 |
| Depreciation Amortization | 1,479 | 2,170 | 18,559 | 4,495 | 5,232 |
| Accounts receivable | 317 | 384 | 199 | 994 | -2,115 |
| Other Working Capital | 1,101 | 222 | -439 | 978 | -1,009 |
| Other Operating Activity | 757 | 217 | 2,569 | 12,860 | 3,333 |
| Operating Cash Flow | $-10,164 | $-7,440 | $-8,876 | $-5,922 | $-3,625 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,458 | -775 | 18,865 | -647 | -46,053 |
| PPE Investments | -24 | 152 | 10 | -1,403 | -1,750 |
| Net Acquisitions | N/A | N/A | N/A | 4,656 | N/A |
| Investing Cash Flow | $8,434 | $-623 | $18,875 | $2,606 | $-47,803 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -285 | -28 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 1,561 |
| Debt Repayment | N/A | N/A | N/A | N/A | -250 |
| Common Stock Issued | 553 | 227 | 468 | 690 | 48,227 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 11,790 |
| Financing Cash Flow | $553 | $227 | $183 | $662 | $61,328 |
| Exchange Rate Effect | N/A | N/A | -187 | 147 | N/A |
| Beginning Cash Position | 9,803 | 17,639 | 7,644 | 10,151 | 251 |
| End Cash Position | 8,626 | 9,803 | 17,639 | 7,644 | 10,151 |
| Net Cash Flow | $-1,177 | $-7,836 | $9,995 | $-2,507 | $9,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,164 | -7,440 | -8,876 | -5,922 | -3,625 |
| Capital Expenditure | -24 | -64 | -69 | -1,403 | -1,750 |
| Free Cash Flow | -10,188 | -7,504 | -8,945 | -7,325 | -5,375 |